NCT07112053 2026-04-06
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
21 trialsNCT07407920 2026-02-12
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04182984 2026-01-30
TREAT-OMG
Tang-Du Hospital
Recruiting
NCT04134260 2026-01-14
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
NRG Oncology
Phase 3 Recruiting
NCT04915508 2025-06-22
EXCALIBUR
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT05945797 2025-03-21
Effects of Dexamethasone on Common Bile Duct Cannulation Time
Gujranwala medical college District Headquarters Hospital, Gujranwala
Phase NA Completed
NCT00004112 2024-09-23
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
University of Nebraska
Phase 3 Completed
NCT05768282 2023-03-16
Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia
E-DA Hospital
Phase 4 Unknown
NCT04810156 2022-12-14
I-HEP
Herlev Hospital
Phase 2 Unknown
NCT01874860 2022-12-01
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
University of Louisville
Phase 2 Completed
NCT04019834 2022-08-03
RELIEF
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT04640220 2022-01-10
Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors
Yeungnam University Hospital
Phase NA Completed
NCT02167633 2021-03-11
Stereocord
Rigshospitalet, Denmark
Phase NA Terminated
NCT04553510 2020-09-17
Treatment of Bevacizumab Followed by Steroid in RN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT03960151 2019-05-22
Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
Hoosier Cancer Research Network
Phase 2 Withdrawn
NCT01908972 2018-12-19
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
Seoul National University Hospital
Phase 4 Completed
NCT03613428 2018-08-03
Ruxolitinib Plus LVP in Patients With R/R ETP-ALL
Sichuan University
Phase 1/2 Unknown
NCT00995722 2017-06-02
EPITOME'
University of Miami
Phase 3 Terminated
NCT00355862 2014-07-30
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
University of Regensburg
Phase 3 Completed
NCT00433940 2013-01-24
Immune Suppression Of Infants Treated With Steroids
Medical College of Wisconsin
Completed
NCT00946374 2009-07-27
HD-MCL2003
Heidelberg University
Phase 2 Unknown